IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Encouragement
Video
Meme Wars

Brands

Yourlist
Quizie
FaithTap
Blessed
All brands

Analysts see recovery potential in Intuitive Surgical and Novo Nordisk amid growth worries — Sep 4, 2026Stock picks across a mix of growth and large-cap names show a balance of long-term upside and near-term headwinds: Intuitive Surgical and Novo Nordisk are presented as attractive long-term buys despite recent challenges, while TXN and ODFL face slowing growth and margin pressure, warranting caution on valuation. Additional lists flag mixed signals for Teradata and RUM Group, Allegro MicroSystems and First Watch as high- or mid-duration risks, Twilio and ADM as examples of growth or margin struggles in large-cap names, underscoring the broader theme of weighing quality against price in today’s market.

Jared Kim Intuitive Surgical has been the steady long term compounder for years, short term wobbles don't scare me off that one.

Temasek Expands Holdings in Teradyne — Jul 22, 2026Temasek Holdings Private Ltd disclosed new or expanded stakes in five companies in the first quarter, including Denison Mine, Teradyne, Intuitive Surgical, Taseko Mines, and Boston Scientific. The positions ranged from about 2.7 million in Taseko to roughly 150.6 million in Boston Scientific, with Denison at 13.2 million, Teradyne at 26.5 million, and Intuitive Surgical at 104.7 million.

J&J Wins FDA De Novo OTTAVA System — Jul 22, 2026Johnson & Johnson has received FDA De Novo clearance for its Ottava robotic surgical system, marking its entry into the U.S. market as a table-integrated, space-saving alternative aimed at general soft-tissue procedures. The company plans a selective U.S. rollout and ongoing global expansion, supported by an inguinal hernia trial and continued development of additional indications and regulatory approvals amid competition from Intuitive Surgical's established da Vinci platform.

Insurers, Medical Stocks Rally Ahead of EarningsBusiness — Jul 20, 2026From penny-stock hopefuls like Vizsla Silver and Clover Health to heavyweight medical names such as Danaher, Intuitive Surgical and Eli Lilly, investors are weighing high-growth potential against execution risk as volumes, profitability, and catalysts drive attention. Insurance stocks Cincinnati Financial, Reinsurance Group of America, Oscar Health, Willis Towers Watson and Aflac are poised to outperform, while Custom Health Holdings’ bid for Evergreen Pharmacy and Alnylam Pharmaceuticals’ RNAi-focused pipeline illustrate ongoing deal activity and biotech risk-reward in a rate-sensitive, geopolitically unsettled market.

IJRWall Street Is Ready To Invest In America’s Energy Future. If Washington Permits It.Jeremy Harrell · 4 min · 50m